NCT05909501Recruiting
Assessment of Geriatric Evaluations Impact on New AML Guidance
AGE-ING (Assessment of Geriatric Evaluations Impact on New AML Guidance) Study
Source: ClinicalTrials.gov · Last updated 2 Oct 2026
Brief summary (registry, in English)
The goal of the study is to measure physiologic age (there is no current formal definition but is meant to imply that patients should be evaluated holistically rather than on age alone) at baseline in newly diagnosed AML patients over 50 years receiving either intensive or non-intensive treatment. This information will be used to evaluate toxicity, early mortality, remission rates and long term survival.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 12 Jun 2023
- Start date
- 25 Oct 2023
- Primary completion date
- 1 Dec 2027
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Diseases
- Acute myeloid leukemia
- NCT number
- NCT05909501
What you commit to
- Study type: Observational
- Planned participants: 100
- From 25 Oct 2023 to the primary completion date, 1 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to understand or unable to sign a written informed consent
- Unable to fill out questionnaires on their own and/or do not have someone to help complete them
Who the study is looking for
- AML diagnosis by peripheral flow cytometry and/or bone marrow aspirate and biopsy
- New diagnosis being considered for new line of treatment
- Age ≥ 50 years.
- Performance status 0,1, and 2
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Abramson Cancer Center at University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.